GRI Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRI research report →
Price Chart
About the company
GRI Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis.
- CEO
- W. Marc Hertz
- IPO
- 2021
- Employees
- 4
- HQ
- La Jolla, CA, US
Get TickerSpark's AI analysis on GRI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $150.02K
- P/E
- -0.04
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.29
- EV/EBITDA
- 1.11
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -134.03%
- ROIC
- -93.76%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-11,977,000
- Net Income
- $-11,956,000-45.7%
- EPS
- $-121.80-37009.1%
- OCF Growth
- -18.3%
- FCF Growth
- -18.3%
- 52W High
- $80.36
- 52W Low
- $1.36
- 50D MA
- $1.75
- 200D MA
- $9.87
- Beta
- -0.66
- RSI (14)
- 50
- Avg Volume
- 182.88K
No earnings-call transcripts are available for GRI yet.
- Free Float
- 100.0%
- Shares Outstanding
- 89.83K
- Float Shares
- 89.82K
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 11 ETFs
Biggest fund positions in GRI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 18, 25 | Kelly Leanne | other | 43,222 |
| Sep 18, 25 | Szekeres David Leslie | other | 39,897 |
| Sep 18, 25 | Baker David Charles | other | 23,605 |
| Sep 18, 25 | SIMPSON CAMILLA V | other | 23,605 |
| Sep 18, 25 | Chaturvedi Vipin | other | 43,222 |
| Sep 18, 25 | Rongen Roelof | other | 23,605 |
| Sep 18, 25 | Hertz Walter Marc | other | 103,067 |
| Aug 26, 25 | Hertz Walter Marc | other | 26,688 |
| Aug 26, 25 | Szekeres David Leslie | other | 10,276 |
| Aug 26, 25 | Baker David Charles | other | 5,994 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our GRI coverage
Recent articles, reports, and earnings notes.
No research on GRI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GRI report →Bitcoin surges above $70K as Trump backs Clarity Act, Treasury ramps up buybacks
nypost.com · Aug 20
Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact
gurufocus.com · Aug 5
Ingram Micro Releases 2025 Sustainable Impact Report
gurufocus.com · Aug 3
Williams Improves on Key Sustainability Metrics Amid Rising Energy Demand
gurufocus.com · Jul 30
Banner Bank Releases New Corporate Responsibility Report
gurufocus.com · Jul 14
Asbury Automotive Group Named in TIME America's Best Companies 2026 List
gurufocus.com · Jul 9
Luxshare Precision Releases 2025 Sustainability Report
gurufocus.com · Jun 23
CROWN HOLDINGS ANNOUNCES PUBLICATION OF ITS 2025 SUSTAINABILITY REPORT "DELIVERING SUSTAINABILITY", HIGHLIGHTING KEY MILESTONES AND PROGRESS TOWARD 2030 GOALS
gurufocus.com · Jun 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.